Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,882 INR | +4.95% | +6.01% | -2.22% |
May. 23 | Jefferies Adjusts Gland Pharma's Price Target to INR2,240 From INR2,400, Keeps at Buy | MT |
May. 23 | Gland Pharma Posts Surge in Fiscal Q4 Consolidated Net Profit | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.22% | 3.55B | |
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Nomura Downgrades Gland Pharma to Reduce From Neutral, Adjusts Price Target to INR1,157 From INR1,524